The pharma industry and its Republican allies in Congress are openly signaling their plans obstruct at every turn as the Biden administration looks to begin implementing a recently passed law allowing Medicare to negotiate drug prices for the first time in its history. They’re using an argument debunked many times before money buys politicians.

The number of young people developing Type 2 diabetes has soared over the past 30 years, driven mainly by rising obesity rates, a new study shows. The mortality rate due to the global disease increased from 0.74 percent per 100,000 to 0.77 per 100,000 in 2019, when new diabetes drugs became a “vanity drug” for rapid weight loss, and Americans still aren’t exercising.